KMT2A and leukemia: In the current study, to identify new potential molecular mechanisms characterizing KMT2A/AFF1+ B-ALL, we investigated, for the first time, the case of monozygotic twins with the discordant diagnosis of KMT2A/AFF1 leukemia by exploiting different “-omics” approaches.